Independent Analysis Examines ColonBroom GLP-1 Booster Ingredient Transparency, Non-Prescription Supplement Category Context, and Company-Reported Formulation Details as Consumer Research Into ...

New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

PALI-2108 is the first and only PDE4 inhibitor in development designed for targeted delivery to the terminal ileum and colon, addressing ...

Researchers have investigated the role that estrogen plays in signaling more gut pain, and it isn't working alone.

PALI-2108 is the first and only PDE4 inhibitor in development targetingthe terminal ileum and colon for treatment of ulcerative colitis (UC) and ...

The final, formatted version of the article will be published soon. Objective: To systematically evaluate the efficacy and safety of traditional Chinese medicine (TCM) for postoperative adjuvant ...

Cases of colorectal cancer in younger adults are climbing worldwide, driven by lifestyle changes and inherited genetic risks. Diet, obesity, and lack of early screening are playing a major role in ...